SALIXIN A/S: Financial statements 2025
CVR: 33776748
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343. The solvency ratio was 10.2%.
- Gross Profit
- DKK 169,447
- Profit/Loss
- DKK 106,174
- Equity
- DKK 124,343
- Total Assets
- DKK 1,217,872
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 169K | 106K | 124K | 0 |
| 2024 | - | -346K | 1.1M | 18K | 0 |
| 2023 | - | -286K | -8.5M | -1M | 1 |
| 2022 | - | 496K | 55K | 4M | 1 |
| 2021 | - | 9.1M | 6.3M | 3.9M | 2 |
Official annual report
How creditworthy is SALIXIN A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
SALIXIN A/S has published its annual report for 2024. Gross profit came to DKK -345,682, and the net result was DKK 1,051,659.
As of June 12, 2025, ALBJERG STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of SALIXIN A/S.
As of June 12, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of SALIXIN A/S.
As of June 12, 2025, Peter Christoffersen has joined the board of directors of SALIXIN A/S.
As of June 12, 2025, Michael Bundgaard has left the board of directors of SALIXIN A/S.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.